LATEST NEWS

LA JOLLA, CA—New research from scientists at La Jolla Institute for Immunology (LJI) suggests people who received COVID-19 vaccines and then experienced “breakthrough” infections are especially well armed against future SARS-CoV-2 infections.
Leading immunologist honored for research into the roots of autoimmunity, cancer development, and more
LJI Research Technician Patrick Kennedy makes scientific breakthroughs in the Myers Lab
Tarke established important U.S.-Italy research collaborations amidst the COVID-19 pandemic
Prebys Foundation celebrates ground-breaking female researchers
LJI scientists share a new, rapid method for studying phosphorylation and other post-translational modifications
A letter from LJI Professor, President, and CEO Erica Ollmann Saphire, Ph.D., MBA
“We feel like—from a foundation standpoint—that we're making a significant contribution to science.”
The art of folding “big data” together to cure disease
A brief look at how AI and machine learning can help beat disease
La Jolla Institute for Immunology has an important responsibility: to train the next generation of world-changing immunologists